Graham Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Graham Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Buy	+75,653	New	+$1.25M	0.02%	438
2025 Q4	–	Sell	-15,834	Closed	-$232K	–	1575
2025 Q3	$232K	Sell	15,834 -33,452	-68%	-$497K	﹤0.01%	982
2025 Q2	$762K	Sell	49,286 -109,474	-69%	-$1.62M	0.01%	672
2025 Q1	$2.36M	Buy	+158,760	New	+$2.22M	0.04%	276
2023 Q4	–	Sell	-11,061	Closed	-$171K	–	1321
2023 Q3	$171K	Buy	+11,061	New	+$171K	﹤0.01%	881

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Graham Capital Management's TAK Position: Q2 2026 in Review

Graham Capital Management opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 75,653 shares worth $1.21M. The stake represents 0.02% of the portfolio and ranks #438 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in TAK as recently as Q3 2025.

Graham Capital Management first reported a position in TAK in Q3 2023 and has held it in 5 quarters since. The position peaked at $2.36M in Q1 2025. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Graham Capital Management held 75,653 shares of Takeda Pharmaceutical worth $1.21M as of Q2 2026.
Takeda Pharmaceutical was a new Graham Capital Management position in Q2 2026.
Takeda Pharmaceutical made up 0.02% of Graham Capital Management's portfolio in Q2 2026, its #438 holding.
Graham Capital Management first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 5 quarters since.
Graham Capital Management's Takeda Pharmaceutical position peaked at $2.36M in Q1 2025.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.